Published by Josh White on 2nd December 2024
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced significant regulatory progress in the UK for its lead asset bexmarilimab on Monday.
URL: http://www.digitallook.com/dl/news/story/34725315/...